EQUITY.GURU podcast - Investing for millennials and madmen
Business:Investing
Developing new prescription medicine for market is a costly and oftentimes, a futile endeavor as drugmakers can spend up to $2.6 billion only to see 12% of their candidates gain approval. When Pfizer fails on two out of three new drugs, retail investors have grown leery of the space, but companies like Aequus Pharmaceuticals (AQS.V) have found a way to bypass this massive regulatory and financial bottleneck by seeking out existing drugs approved in other countries and bringing them to Canada for market approval.
Spending 12-18 months rather than the standard 8-10 years for new drug approval, Aequus also benefits from low fixed costs that allow the company to profitably operate in a relatively small marketplace such as Canada in niche areas including neurology, ophthalmology and transplant. Positioned for growth with $2.0 million cash in the till, Aequus is a steady bet in an uncertain industry. As such, Equity Guru’s own Chris Parry spoke with company CEO and chairman, Doug Janzen, to get a better look at Aequus unique de-risked approach and its potential for investors. Tune in!
Equity.Guru podcast: Pasha Brands (CRFT.C) helps to make premium grey market bud legal again with new Health Canada program
Equity.Guru podcast: Weekly Crypto Countdown July 5, 2019
Equity Guru podcast: The week in weed ICYMI (July 5, 2019)
Equity.Guru podcast: Yield Growth (BOSS.C) conducts all-out assault on wellness sector with beautiful cannabis-based formulas
Equity.Guru podcast: Nexus Gold (NXS.V) adds to West African assets with Canadian acquisition as gold runs with the bulls
Equity.Guru podcast: Hemptown Organics grows buttloads of high-grade hemp on road to IPO
Equity.Guru podcast: News extra - Slack's (WORK.NYSE) mulit-billion-dollar public market debut
Equity.Guru podcast: Great Bear Resources (GBR.V) proving up high-grade gold project near Red Lake
Equity.Guru podcast: News extra - Canada's new edible legislation and its impact
Equity.Guru podcast: GTEC Holdings’ (GTEC.V) grand plan to build customer loyalty
Equity.Guru podcast: Renaissance Oil (ROE.V) partners with Russian giant in Mexico
Equity.Guru podcast: Cannabis brand king, Marc Lustig, outlines direction for Origin House (OH.C) in wake of $1.1 billion acquisition
Equity.Guru podcast: Chemesis International (CSI.C) angles for piece of 627 million LatAm cannabis market
Mining investment legend, Rick Rule, on Atlantic Gold (AGB.V), Australian miners, mining M&A and blockchain
Equity.Guru podcast: Khiron Life Sciences (KHRN.V) capitalizing on international cannabis markets
Equity.Guru podcast: Plus Products (PLUS.C) - how to conquer the California cannabis market
EQUITY.GURU podcast: Patriot One Technologies (PAT.T) - the hardware that protects soft targets
Equity.Guru podcast: Barrian Mining (BARI.V) goes public to bring gold mining to millennials
Equity.Guru podcast: VitalHub (VHI.V) builds healthcare solution business for the value investor
Equity.Guru podcast: Ceylon Graphite's (CYL.V) world-class Sri Lankan graphite connection
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Dubai Property Podcast
IBKR Podcasts
The Ramsey Show
The Clark Howard Podcast